Unlock the potential of biosimilars: Improve patient access and long-term healthcare sustainability
Evvnt Promotion / evvnt
Archivio
10.05.2021 Online, Germany
Time: 3:00 pm - 5:00 pm
Temi della conferenza
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Since the world’s first biosimilar was approved in 2006, these treatments have had a positive impact on patient access and healthcare system sustainability. However, despite 15 years of progress, several challenges need to be addressed in order to unlock their full potential.
Professional congress organizer (PCO)
Reuters Events
Reuters Events
Informazioni ed Iscrizioni:
Mr. Josh Bramwell
Medicina General
Lingua
Inglese
Inglese
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
